PEPGEN
PepGen empowers nucleic acid therapeutics to go the distance. PepGen's ambition is to unlock the potential of nucleic acid therapeutics by leveraging the drug delivery capabilities of their innovative product engine. PepGen's initial focus is on the application of this technology to the efficacious delivery of antisense oligonucleotides, and they are advancing novel conjugate therapeutics to the clinic.
PEPGEN
Industry:
Biotechnology Clinical Trials Medical
Founded:
2018-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.pepgen.com
Total Employee:
11+
Status:
Active
Contact:
+44 1865 618 820
Email Addresses:
[email protected]
Total Funding:
159.58 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Sitelinks Search Box Euro Organization Schema IPv6
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
HebeCell
HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases.
Home Biosciences
Home Biosciences is a European venture builder dedicated to biotech.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Onego Bio
Onego Bio is a smart protein is a piece of cake.
Upacjenta
Upacjenta is to popularize preventive laboratory tests among Polish women and Poles.
Venn Life Sciences
Contract research providing clinical trial services from pre-clinical to Phase III
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Laurion Capital Management
Laurion Capital Management investment in Venture Round - Pepgen
CureDuchenne Ventures
CureDuchenne Ventures investment in Venture Round - Pepgen
Viking Global Investors
Viking Global Investors investment in Venture Round - Pepgen
Gray’s Creek Capital Partners
Gray’s Creek Capital Partners investment in Venture Round - Pepgen
Adage Capital Management
Adage Capital Management investment in Venture Round - Pepgen
Samsara BioCapital
Samsara BioCapital investment in Venture Round - Pepgen
Qatar Investment Authority
Qatar Investment Authority investment in Venture Round - Pepgen
RA Capital Management
RA Capital Management investment in Venture Round - Pepgen
Tudor Investments
Tudor Investments investment in Venture Round - Pepgen
Deerfield
Deerfield investment in Venture Round - Pepgen
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-08 | PepGen Bolsters R&D Team with Appointment of Jaya Goyal, Ph.D., as Executive Vice President of Research and Preclinical Development |
Official Site Inspections
http://www.pepgen.com Semrush global rank: 4.28 M Semrush visits lastest month: 2.69 K
- Host name: 2.124.145.34.bc.googleusercontent.com
- IP address: 34.145.124.2
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Pepgen"
About – PepGen
Prior to PepGen, Kyle held roles of increasing responsibility with the finance group at Orchard Therapeutics, where he was a key partner in the Company’s IPO and multiple successful …See details»
Investor Relations | PepGen
May 8, 2025 The Investor Relations website contains information about PepGen's business for stockholders, potential investors, and financial analysts.See details»
Pepgen - Crunchbase Company Profile & Funding
Where is Pepgen's headquarters? Pepgen is located in Oxford, Oxfordshire, United Kingdom. Who invested in Pepgen? Pepgen has 20 investors including Janus Henderson Investors and …See details»
PepGen Reports Second Quarter 2025 Financial Results and Recent ...
Jun 30, 2025 BOSTON -- (BUSINESS WIRE)--Aug. 7, 2025-- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide …See details»
PepGen - LinkedIn
PepGen Biotechnology Research Boston, Massachusetts 11,589 followers Better Technology. Better Delivery. Developing a new generation of disease-modifying therapies.See details»
Pipeline – PepGen
Pipeline Therapies with the potential to halt disease progression Utilizing its Enhanced Delivery Oligonucleotide (EDO) technology, PepGen discovered PGN-EDODM1, a novel, potentially disease-modifying, peptide-conjugated …See details»
PepGen 2025 Company Profile: Stock Performance & Earnings
Information on stock, financials, earnings, subsidiaries, investors, and executives for PepGen. Use the PitchBook Platform to explore the full profile.See details»
What is Brief History of Pepgen Company? – …
Jul 24, 2025 This brief exploration into the PepGen history will delve into the key milestones of this innovative biotechnology company. We'll examine its pioneering work in gene therapy, its …See details»
Pepgen - 2025 Company Profile & Funding - Tracxn
May 1, 2025 Pepgen - Provider of various therapeutics. Public Company. Raised a total funding of $158M over 3 rounds from 5 investors.See details»
PepGen Inc. (PEPG) Company Profile & Facts - Yahoo Finance
See the company profile for PepGen Inc. (PEPG) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives …See details»
How Does Pepgen Company Work? – CanvasBusinessModel.com
Jul 12, 2025 To truly appreciate PepGen's potential, we must delve into its Pepgen working process and Pepgen company operations. This involves examining its Pepgen drug …See details»
PepGen Inc, PEPG:NSQ profile - FT.com - Financial Times
Aug 1, 2025 PepGen Inc (PEPG:NSQ) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
PepGen - businessabc.net
Jul 11, 2025 PepGen was founded in 2017 by scientists and researchers looking to make an impact on genomic medicine. Since then, the company has successfully developed …See details»
PepGen Company Profile | Management and Employees List
Find contact information for PepGen. Learn about their Research & Development, Business Services market share, competitors, and PepGen's email format.See details»
PepGen - News, Locations, Executives and Competitors - Usearch
Overview Founded in 2018, PepGen clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the tre...See details»
PepGen (PEPG) Company Profile & Description - Stock Analysis
May 6, 2022 Company profile for PepGen Inc. (PEPG) stock, with a description, list of executives, contact details and other key facts.See details»
PepGen Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
May 7, 2025 Explore PepGen Ltd. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 58 news, and 1 literature, Drug:Interferon-tau(Pepgen).See details»
PepGen Inc. - Executive Bio, Top Executies, and Transitions
View the organization profile of PepGen Inc.,James McArthur, Ph.D., has served as our President and Chief Executive Officer and a member of our board of directors since January 2021. From …See details»
PepGen Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore PepGen Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 87 news, and 11 literature, Disease Domain:Nervous System ...See details»
PepGen Inc. - AnnualReports.com
PepGen Inc. is a clinical-stage biotechnology company advancing the next-generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular …See details»